Blockage of STAT3 Signaling Pathway with a Decoy Oligodeoxynucleotide Inhibits Growth of Human Ovarian Cancer Cells

REFERENCES

• Fukada T, Ohtani T, Yoshida Y, Shirogane T, Nishida K, Nakajima K, Hibi M, Hirano T. Stat3 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition. EMBO J 1998;15:6670–6677.
   Google Scholar
• Chakraborty A, Tweardy DT. Stat3 and G-CSF-induced myeloid differentiation. Leuk Lymph 1998;30:433–442.
   PubMed Web of Science ®Google Scholar
• Fukada T, Hibi M, Yamanaka Y, Takahashi-Tezuka M, Fujitani Y, Yamaguchi T, Nakajima K, Hirano T. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity 1996;5:449–460.
   PubMed Web of Science ®Google Scholar
• Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, Yoshida N, Kishimoto T, Akira S. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci USA 1997;94:3801–3804.
   PubMed Web of Science ®Google Scholar
• Akira, S. Roles of STAT3 defined by tissue-specific gene targeting. Oncogene 2000;19:2607–2611.
   PubMed Web of Science ®Google Scholar
• Yu H, Jove, R. The STATs of cancer-new molecular targets come of age. Nat Rev Cancer 2004;4(2):97–105.
   PubMed Web of Science ®Google Scholar
• Bromberg, J. Stat proteins and oncogenesis. J Clin Invest 2002;109:1139–1142.
   PubMed Web of Science ®Google Scholar
• Darnell, JE Jr. STATs and gene regulation. Science 1997;277: 1630–1635.
   PubMed Web of Science ®Google Scholar
• Bowman T, Garcia R, Turkson J, Jove R. STATs in oncogenesis. Oncogene 2000;19:2474–2488.
   PubMed Web of Science ®Google Scholar
• Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernández-Luna JL, Nuñez G, Dalton WS, Jove, R. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 1999;10:105–115.
   PubMed Web of Science ®Google Scholar
• Grandis JR, Drenning SD, Zeng Q, Watkins SC, Melhem MF, Endo S, Johnson DE, Huang L, He Y, Kim, JD. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc Natl Acad Sci USA 2000;97:4227–4232.
   PubMed Web of Science ®Google Scholar
• Huang M, Page C, Reynolds RK, Lin, J. Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells. Gynecol Oncol 2000;79:67–73.
   PubMed Web of Science ®Google Scholar
• Kube D, Holtick U, Vockerodt M, Ahmadi T, Haier B, Behrmann I, Heinrich PC, Diehl V, Tesch, H. STAT3 is constitutively activated in Hodgkin cell lines. Blood 2001;98:762–770.
   PubMed Web of Science ®Google Scholar
• Epling-Burnette PK, Liu JH, Catlett-Falcone R, Turkson J, Oshiro M, Kothapalli R, Li Y, Wang JM, Yang-Yen HF, Karras J, Jove R, Loughran, TP Jr. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest 2001;107:351–362.
   PubMed Web of Science ®Google Scholar
• Mora LB, Buettner R, Seigne J, Diaz J, Ahmad N, Garcia R, Bowman T, Falcone R, Fairclough R, Cantor A, Muro-Cacho C, Livingston S, Karras J, Pow-Sang J, Jove, R. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. Cancer Res 2002;62:6659–6666.
   PubMed Web of Science ®Google Scholar
• Scholz A, Heinze S, Detjen KM, Peters M, Welzel M, Hauff P, Schirner M, Wiedenmann B, Rosewicz, S. Activated signal transducer and activator of transcription 3 (STAT3) supports the malignantphenotype of human pancreatic cancer. Gastroenterology 2003;125:891–905.
   PubMed Web of Science ®Google Scholar
• Song L, Turkson J, Karras JG, Jove R, Haura, EB. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells. Oncogene 2003;22:4150–4165.
   PubMed Web of Science ®Google Scholar
• Kanda N, Seno H, Konda Y, Marusawa H, Kanai M, Nakajima T, Kawashima T, Nanakin A, Sawabu T, Uenoyama Y, Sekikawa A, Kawada M, Suzuki K, Kayahara T, Fukui H, Sawada M, Chiba, T. STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene 2004;23:4921–4929.
   PubMed Web of Science ®Google Scholar
• Xie TX, Huang FJ, Aldape KD, Kang SH, Liu M, Gershenwald JE, Xie K, Sawaya R, Huang, S. Activation of Stat3 in Human Melanoma Promotes Brain Metastasis. Cancer Res 2006;66:3188–3196.
   PubMed Web of Science ®Google Scholar
• Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D, Yoder S, Enkemann S, Eschrich S, Lee JH, Beam CA, Cheng J, Minton S, Muro-Cacho CA, Jove, R. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res 2006;12:11–19.
   PubMed Web of Science ®Google Scholar
• Silver DL, Naora H, Liu J, Cheng W, Montell, DJ. Activated signal transducer and activator of transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility. Cancer Res 2004;64:3550–3558.
   PubMed Web of Science ®Google Scholar
• Niu G, Shain KH, Huang M, Ravi R, Bedi A, Dalton WS, Jove R, Yu, H. Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrest. Cancer Res 2001;61:3276–3280.
   PubMed Web of Science ®Google Scholar
• Konnikova L, Kotecki M, Kruger MM, Cochran, BH. Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells. BMC Cancer 2003;3:23.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang J, Wang L, Wei H, Tian, Z. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice. BMC Cancer 2007;7:149–159.
   PubMed Web of Science ®Google Scholar
• Leong PL, Andrews GA, Johnson DE, Dyer KF, Xi S, Mai JC, Robbins PD, Gadiparthi S, Burke NA, Watkins SF, Grandis, JR. Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth. Proc Natl Acad Sci USA 2003;100:4138–4143.
   PubMed Web of Science ®Google Scholar
• Sun X, Zhang J, Wang L, Tian, Z. Growth inhibition of human hepatocellular carcinoma cells by blocking STAT3 activation with decoy-ODN. Cancer Letters 2008;262:201–213.
   PubMed Web of Science ®Google Scholar
• Gu J, Li G, Sun T, Su Y, Zhang X, Shen J, Tian Z, Zhang, J. Blockage of the STAT3 signaling pathway with a decoy oligonucleotide suppresses growth of human malignant glioma cells. J Neurooncol 2008;89(1):9–17.
   PubMed Web of Science ®Google Scholar
• Morishita R, Tomita N, Kaneda Y, Ogihara, T. Molecular therapy to inhibit NFkappaB activation by transcription factor decoy oligonucleotides. Curr Opin Pharmacol 2004;4:139–146.
   PubMed Web of Science ®Google Scholar
• Xi S, Gooding WE, Grandis, JR. In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy. Oncogene 2005;24:970–979.
   PubMed Web of Science ®Google Scholar